Latest Insider Transactions at Biodesix Inc (BDSX)
This section provides a real-time view of insider transactions for Biodesix Inc (BDSX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of BIODESIX INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of BIODESIX INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 31
2022
|
Matthew Strobeck |
BUY
Exercise of conversion of derivative security
|
Direct |
20,044
+1.99%
|
-
|
|
Mar 31
2022
|
Jean M. Franchi |
BUY
Exercise of conversion of derivative security
|
Direct |
20,044
+50.0%
|
-
|
|
Jan 13
2022
|
Robin Harper Cowie CFO, Sec'y & Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,679
+5.79%
|
$0
$0.42 P/Share
|
|
Dec 30
2021
|
John Patience |
BUY
Open market or private purchase
|
Indirect |
160,919
+18.24%
|
$643,676
$4.35 P/Share
|
|
Dec 30
2021
|
Matthew Strobeck |
BUY
Open market or private purchase
|
Indirect |
147,800
+35.49%
|
$591,200
$4.35 P/Share
|
|
Dec 30
2021
|
Jack W Schuler |
BUY
Open market or private purchase
|
Indirect |
2,298,850
+21.36%
|
$9,195,400
$4.35 P/Share
|
|
Dec 20
2021
|
Charles M Watts |
BUY
Open market or private purchase
|
Direct |
5,855
+42.71%
|
$23,420
$4.29 P/Share
|
|
Nov 23
2021
|
John Patience |
BUY
Open market or private purchase
|
Indirect |
10,000
+0.51%
|
$60,000
$6.18 P/Share
|
|
Nov 22
2021
|
Jack W Schuler |
BUY
Open market or private purchase
|
Indirect |
20,000
+0.32%
|
$120,000
$6.34 P/Share
|
|
Nov 19
2021
|
Jack W Schuler |
BUY
Open market or private purchase
|
Indirect |
60,000
+0.97%
|
$360,000
$6.5 P/Share
|
|
Nov 18
2021
|
Jack W Schuler |
BUY
Open market or private purchase
|
Indirect |
28,361
+0.46%
|
$170,166
$6.33 P/Share
|
|
Nov 18
2021
|
John Patience |
BUY
Open market or private purchase
|
Indirect |
9,497
+0.49%
|
$56,982
$6.34 P/Share
|
|
Nov 17
2021
|
Jack W Schuler |
BUY
Open market or private purchase
|
Indirect |
20,000
+0.33%
|
$120,000
$6.51 P/Share
|
|
Nov 17
2021
|
Robin Harper Cowie CFO, Sec'y & Treasurer |
BUY
Open market or private purchase
|
Direct |
1,000
+2.33%
|
$6,000
$6.51 P/Share
|
|
Nov 17
2021
|
Scott Hutton President & CEO |
BUY
Open market or private purchase
|
Direct |
3,000
+23.51%
|
$18,000
$6.46 P/Share
|
|
Aug 19
2021
|
Jack W Schuler |
BUY
Open market or private purchase
|
Indirect |
50,000
+0.82%
|
$350,000
$7.69 P/Share
|
|
Aug 19
2021
|
John Patience |
BUY
Open market or private purchase
|
Indirect |
8,396
+0.44%
|
$67,168
$8.04 P/Share
|
|
Aug 17
2021
|
Jack W Schuler |
BUY
Open market or private purchase
|
Indirect |
29,440
+0.49%
|
$206,080
$7.18 P/Share
|
|
Aug 17
2021
|
John Patience |
BUY
Open market or private purchase
|
Indirect |
1,604
+0.08%
|
$11,228
$7.12 P/Share
|
|
Aug 13
2021
|
Jack W Schuler |
BUY
Open market or private purchase
|
Indirect |
232,000
+3.75%
|
$1,624,000
$7.5 P/Share
|
|
Apr 05
2021
|
Robert William Georgantas Iii Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,219
+48.68%
|
$0
$0.77 P/Share
|
|
Apr 01
2021
|
Robin Harper Cowie CFO, Sec'y & Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct |
38,713
+36.0%
|
$38,713
$1.08 P/Share
|
|
Dec 18
2020
|
Gary Anthony Pestano Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
82,166
+22.29%
|
$82,166
$1.41 P/Share
|
|
Dec 07
2020
|
John Patience |
BUY
Exercise of conversion of derivative security
|
Direct |
58,597
+39.29%
|
$351,582
$6.83 P/Share
|
|
Dec 07
2020
|
Jack W Schuler |
BUY
Exercise of conversion of derivative security
|
Indirect |
58,597
+0.51%
|
$351,582
$6.83 P/Share
|
|
Dec 07
2020
|
Matthew Strobeck |
BUY
Exercise of conversion of derivative security
|
Direct |
58,597
+2.98%
|
$351,582
$6.83 P/Share
|
|
Oct 30
2020
|
Charles M Watts |
BUY
Open market or private purchase
|
Direct |
2,000
+50.0%
|
$36,000
$18.0 P/Share
|
|
Oct 30
2020
|
Scott Hutton President & CEO |
BUY
Open market or private purchase
|
Direct |
5,500
+50.0%
|
$99,000
$18.0 P/Share
|
|
Oct 30
2020
|
Robin Harper Cowie CFO, Sec'y & Treasurer |
BUY
Open market or private purchase
|
Direct |
1,000
+50.0%
|
$18,000
$18.0 P/Share
|
|
Oct 30
2020
|
Robert William Georgantas Iii Chief Scientific Officer |
BUY
Open market or private purchase
|
Indirect |
100
+50.0%
|
$1,800
$18.0 P/Share
|
|
Oct 30
2020
|
Robert William Georgantas Iii Chief Scientific Officer |
BUY
Open market or private purchase
|
Direct |
555
+50.0%
|
$9,990
$18.0 P/Share
|
|
Oct 30
2020
|
Hany Massarany |
BUY
Open market or private purchase
|
Direct |
7,500
+50.0%
|
$135,000
$18.0 P/Share
|
|
Oct 30
2020
|
John Patience |
BUY
Open market or private purchase
|
Indirect |
30,000
+50.0%
|
$540,000
$18.0 P/Share
|
|
Oct 30
2020
|
John Patience |
BUY
Conversion of derivative security
|
Indirect |
4,722,399
+22.9%
|
$66,113,586
$14.4 P/Share
|
|
Oct 30
2020
|
Jack W Schuler |
BUY
Open market or private purchase
|
Indirect |
277,777
+50.0%
|
$4,999,986
$18.0 P/Share
|
|
Oct 30
2020
|
Jack W Schuler |
BUY
Conversion of derivative security
|
Indirect |
5,666,822
+22.16%
|
$79,335,508
$14.4 P/Share
|
|
Oct 30
2020
|
Matthew Strobeck |
BUY
Open market or private purchase
|
Indirect |
83,333
+50.0%
|
$1,499,994
$18.0 P/Share
|
|
Oct 30
2020
|
Matthew Strobeck |
BUY
Conversion of derivative security
|
Indirect |
54,775
+46.92%
|
$766,850
$14.4 P/Share
|
|
Oct 30
2020
|
Matthew Strobeck |
BUY
Conversion of derivative security
|
Direct |
908,378
+28.89%
|
$12,717,292
$14.4 P/Share
|